GI Lectures 34β35: Liver Disease I & II
HoyaDocs β GI Block | USMLE Step 1 Preparation
GI Lectures 34β35 β Overview
Liver Disease I & II Β· HoyaDocs GI Block
Page Summaries
Injury Patterns, LFTs & Clinical Syndromes
- Six histologic injury patterns (hepatitic, cholestatic, steatotic, vascular, biliary, mass)
- True function labs (ABC PT) vs injury markers (AST/ALT/Alk phos/GGT)
- Bilirubin metabolism β Gilbert / Crigler-Najjar / Dubin-Johnson / Rotor
- Cholestasis patterns β PBC (AMA) vs PSC (p-ANCA, UC)
- Zone-3 acetaminophen necrosis; King's College criteria; six portal HTN complications
Cirrhosis
- Stellate-cell activation β bridging fibrosis + regenerative nodules
- Major causes mnemonic "A BIG MESS" (ALD, B/C hepatitis, Iron/Wilson, MASH, etc.)
- Micronodular vs macronodular histology
- Compensated β decompensated continuum; Child-Pugh vs MELD
- Six decompensation complications: ascites/SBP, varices, HE, HRS, HPS, HCC
Alcohol-Related Liver Disease
- Ethanol metabolism β ADH, ALDH2, CYP2E1
- Elevated NADH:NADβΊ consequences (hypoglycemia, lactic acidosis, steatosis)
- Acetaldehyde as a Group 1 carcinogen; ALDH2*2"Asian flushing"
- ALD spectrum: steatosis β alcoholic hepatitis β cirrhosis
- AST:ALT > 2, Mallory-Denk bodies, neutrophilic satellitosis, perivenular fibrosis
Viral & Autoimmune Hepatitis
- Hep AβE β routes, chronicity, complications
- Complete HBV serology including window period
- Acute histology (Councilman bodies, ballooning) vs chronic interface hepatitis
- Extrahepatic disease: HBV β PAN, HCV β cryoglobulinemia/MPGN
- AIH types 1 (ANA/ASMA) and 2 (anti-LKM1)
Vascular Disease of the Liver
- Chronic passive congestion β nutmeg liver; zone-3 vulnerability
- Three anatomic levels of outflow obstruction β sinusoidal, hepatic vein, supra-hepatic
- Budd-Chiari (caudate hypertrophy) vs SOS/VOD (after HSCT, defibrotide)
- Cardiac cirrhosis β high-SAAG, high-protein ascites
Official Learning Objectives Map
Click any objective to expand. Each shows the specific content, sections, and practice questions that cover it.
LOs 1β3 β Liver Injury Patterns, Function & Clinical Syndromes
Patterns of injury Β· LFTs Β· Jaundice Β· Cholestasis Β· Hepatic failure Β· Portal hypertension Β· HoyaDocs GI Block
- LO 1: Describe the general patterns of liver injury.
- LO 2: Correlate the abnormalities of liver function with clinical signs and potential complications.
- LO 3: Describe the clinical syndromes of liver disease: jaundice, cholestasis, hepatic failure, chronic liver disease, portal hypertension.
▼Six Major Histologic Injury Patterns
β The liver has a limited vocabulary for responding to injury β nearly every insult produces one of six recognizable histologic patterns, and recognizing the pattern narrows the differential immediately.
π₯ Pattern 1 β Hepatitic (Inflammatory)
Hepatocyte injury with lobular inflammation. Dominant lesion is hepatocyte apoptosis (Councilman bodies β shrunken, eosinophilic apoptotic hepatocytes) and ballooning degeneration (swollen, pale hepatocytes β failing cells). Portal tracts contain lymphocytes; if inflammation spills across the limiting plate into the lobule, call it interface hepatitis (chronic).
Think: viral hepatitis, autoimmune hepatitis, drug-induced hepatitis (DILI), ischemia.
Labs: AST/ALT >> Alk phos (hepatocellular pattern).
π’ Pattern 2 β Cholestatic
Impaired bile flow. Histology shows bile plugs in canaliculi (brown/green pigment between hepatocytes), hepatocyte"feathery degeneration" from bile toxicity, and bile duct proliferation in chronic cases.
Think: bile duct obstruction (stone, stricture, tumor), primary biliary cholangitis, primary sclerosing cholangitis, drug-induced cholestasis.
Labs: Alk phos & GGT >> AST/ALT; conjugated hyperbilirubinemia.
π§ Pattern 3 β Steatotic (Fatty)
Accumulation of lipid droplets within hepatocytes. Two morphologies:
- Macrovesicular β a single large fat droplet pushes the nucleus to the side (most common; alcohol, obesity, diabetes, MASLD).
- Microvesicular β many small droplets; nucleus stays central. More dangerous; suggests mitochondrial injury (Reye syndrome, acute fatty liver of pregnancy, valproate toxicity, tetracyclines).
When steatosis is accompanied by inflammation and hepatocyte ballooning, it becomes steatohepatitis (MASH/NASH or alcoholic hepatitis).
π©Έ Pattern 4 β Vascular
Injury to sinusoids or central veins. Classic finding is centrilobular (zone 3) congestion and hemorrhagic necrosis β red blood cells pool in sinusoids around central veins, with loss of hepatocytes.
Think: right heart failure ("nutmeg liver"), Budd-Chiari syndrome, sinusoidal obstruction syndrome (SOS/VOD), shock liver.
π³ Pattern 5 β Biliary
Targeting of bile ductules and bile ducts. Expect bile duct destruction or proliferation, portal fibrosis, and sometimes granulomas (PBC). Can overlap clinically with cholestatic pattern but histologically focuses on duct epithelium.
Think: PBC (florid duct lesion), PSC (onion-skin periductal fibrosis), biliary atresia (infants).
π― Pattern 6 β Mass Lesion
Focal lesion: benign (hemangioma, focal nodular hyperplasia, hepatic adenoma) or malignant (hepatocellular carcinoma, cholangiocarcinoma, metastasis). Evaluate with imaging first; biopsy only when imaging is indeterminate because of bleeding risk.
- Councilman body = apoptotic hepatocyte (viral/AIH classic).
- Ballooning = dying hepatocyte (steatohepatitis, DILI).
- Interface hepatitis = chronic hepatitis hallmark (AIH, chronic HCV).
- Macrovesicular steatosis = alcohol/obesity; microvesicular = mitochondrial toxicity.
- Students lump all"fatty liver" together. On Step 1, microvesicular steatosis is the scary one β it points to mitochondrial Ξ²-oxidation failure. Classic vignettes: child with viral illness given aspirin (Reye syndrome), third-trimester pregnancy with vomiting and elevated ammonia (acute fatty liver of pregnancy), or a patient on valproate/tetracycline with sudden liver failure.
- Macrovesicular is the chronic, reversible pattern of alcohol/MASLD.
▼Liver Function Tests & Interpretation
β"LFTs" is a misnomer β AST, ALT, alk phos, and GGT measure hepatocyte injury, not function. True function tests are albumin, bilirubin, and PT/INR.
π§ͺ Markers of Injury (Hepatocellular vs. Cholestatic)
| Marker | What it reflects | Key points |
|---|---|---|
| ALT (alanine aminotransferase) | Hepatocyte injury β cytoplasmic enzyme | More liver-specific than AST. ββ in viral hepatitis, DILI. |
| AST (aspartate aminotransferase) | Hepatocyte injury β cytoplasm + mitochondria | Also in muscle, RBCs, heart. AST > ALT (2:1) suggests alcoholic liver disease. |
| Alk phos (ALP) | Biliary epithelium / obstruction | Also in bone, placenta. Elevated in cholestasis, mets, PBC, PSC. |
| GGT | Biliary β confirms liver source of βALP | Also β in heavy alcohol use (enzyme induction). |
- Hepatocellular pattern: ALT (& AST) markedly elevated, ALP near normal. Ratio ALT/ALP (as fold-elevation) > 5.
- Cholestatic pattern: ALP markedly elevated, ALT mildly elevated. Ratio < 2.
- Mixed: ratio 2β5.
π― True Liver Function Tests
| Test | What it measures | Abnormality implies |
|---|---|---|
| Albumin | Synthetic function (half-life ~20 days) | Low = chronic hepatic dysfunction or malnutrition/nephrotic syndrome. Slow to change. |
| PT / INR | Synthetic function β factors II, VII, IX, X (vit-K-dependent) | Prolonged = acute OR chronic liver dysfunction. Factor VII has ~6-hr half-life β earliest marker of acute failure. |
| Bilirubin (total & direct) | Uptake, conjugation, excretion | β Indirect: hemolysis, Gilbert, Crigler-Najjar. β Direct: obstruction, intrahepatic cholestasis, Dubin-Johnson, Rotor. |
| Ammonia | Urea-cycle capacity (hepatic detox) | Rises with hepatic failure β hepatic encephalopathy. |
A β Albumin Β· B β Bilirubin Β· C β Coagulation (PT/INR)
- These three tell you whether the liver is working.
- AST/ALT/ALP only tell you whether it is injured.
- A hepatocyte can be badly damaged with normal"LFTs" (burned-out cirrhosis) β synthetic labs always win.
AST > ALT in a 2:1 ratio is almost pathognomonic for alcoholic liver disease in the real world. Mechanism: alcohol depletes pyridoxine (B6), which ALT needs more than AST does; mitochondrial AST also leaks with alcohol injury. Nearly every other hepatitis has ALT > AST.
▼Jaundice & Bilirubin Metabolism
β Yellow skin/sclerae appears when total bilirubin exceeds ~2.5 mg/dL. The step at which bilirubin metabolism breaks tells you the cause.
π¬ The Normal Pathway (memorize cold)
- RBC breakdown β heme β biliverdin β unconjugated (indirect) bilirubin β water-insoluble, bound to albumin, transported to liver.
- Hepatocyte uptake via OATP.
- Conjugation with glucuronic acid by UGT1A1 β conjugated (direct) bilirubin β water-soluble.
- Excretion into bile canaliculi via MRP2.
- Gut bacteria convert to urobilinogen β most excreted in stool (stercobilin, brown color); some reabsorbed and excreted in urine (urobilin, yellow color).
π Classification of Hyperbilirubinemia
| Type | Mechanism | Classic causes | Urine bilirubin |
|---|---|---|---|
| Unconjugated (indirect) β pre-hepatic | Overproduction or impaired uptake/conjugation | Hemolysis, neonatal physiologic, Gilbert (stress/fasting), Crigler-Najjar | Absent (unconjugated is albumin-bound β cannot filter) |
| Conjugated (direct) β hepatic/post-hepatic | Defective excretion or obstruction | Dubin-Johnson, Rotor, hepatitis, stone/stricture/tumor in biliary tree | Present (water-soluble, dark urine) |
𧬠Inherited Hyperbilirubinemias (Step 1 classics)
Gilbert syndrome
Mild, intermittent unconjugated hyperbilirubinemia triggered by fasting, stress, illness, or exercise. UGT1A1 activity reduced to ~30%. Benign, extremely common (~5% of population). Normal liver on biopsy.
Crigler-Najjar type I
Complete absence of UGT1A1. Severe unconjugated hyperbilirubinemia in newborns β kernicterus (bilirubin deposition in basal ganglia β permanent neurologic damage or death). Treatment: phototherapy Β± liver transplant.
Dubin-Johnson & Rotor
Defective hepatic excretion of conjugated bilirubin. Mild, benign, direct hyperbilirubinemia. Dubin-Johnson = black liver (MRP2 defect, grossly pigmented on biopsy). Rotor = no pigmentation, milder (OATP defect).
- Dark urine with pale stools = conjugated hyperbilirubinemia from obstructive/post-hepatic cause (bile cannot reach the gut). Classic for pancreatic head tumor, common bile duct stone.
- Dark urine with normal stools = intrahepatic conjugated hyperbilirubinemia (hepatitis) β some bile still reaches gut.
- No bilirubin in urine despite jaundice = unconjugated (hemolysis, Gilbert).
▼Cholestasis
β Cholestasis = impaired bile flow, either from obstruction (extrahepatic) or failure of hepatocyte/canalicular transport (intrahepatic). The clinical consequences flow from bile failing to reach the duodenum.
π Intrahepatic vs. Extrahepatic
| Intrahepatic | Extrahepatic (obstructive) | |
|---|---|---|
| Mechanism | Defective hepatocyte/canalicular secretion | Mechanical blockage of ducts |
| Causes | PBC, PSC (intra-duct), pregnancy cholestasis, DILI (estrogens, erythromycin, anabolic steroids), sepsis, TPN, genetic (PFIC) | CBD stone, pancreatic head cancer, cholangiocarcinoma, PSC (extra-duct), biliary atresia |
| Imaging | Non-dilated ducts | Dilated ducts on US/MRCP |
π§ββοΈ Clinical Features
- Jaundice with conjugated hyperbilirubinemia.
- Pruritus β retained bile salts deposit in skin; severe, classic for PBC and pregnancy cholestasis.
- Pale, fatty stools (steatorrhea) β no bile salts in gut β malabsorption of fats and fat-soluble vitamins (A, D, E, K).
- Dark urine β conjugated bilirubin filtered and excreted.
- Hypercholesterolemia β xanthomas (especially periocular xanthelasmas in PBC).
- Prolonged PT from vitamin K malabsorption β corrects with IV/IM vitamin K (unlike PT prolongation from synthetic failure).
- Labs: ββ ALP, β GGT, β direct bilirubin, modest β AST/ALT.
- Charcot triad (ascending cholangitis): fever, RUQ pain, jaundice.
- Reynolds pentad: add hypotension + altered mental status = suppurative cholangitis β emergency ERCP.
- PT correction with vitamin K differentiates cholestasis (corrects) from hepatocellular failure (doesn't).
- PBC (primary biliary cholangitis): middle-aged woman, pruritus, xanthomas, anti-mitochondrial Ab (AMA), florid duct lesion, associated with other autoimmune disease. Intrahepatic ducts only.
- PSC (primary sclerosing cholangitis): young man with ulcerative colitis, p-ANCA,"onion-skin" periductal fibrosis,"beaded" intra- AND extra-hepatic ducts on MRCP. High risk of cholangiocarcinoma.
▼Acute Hepatitis
β Acute hepatitis = new-onset hepatocellular inflammation lasting < 6 months. Classic prodrome (malaise, nausea, RUQ discomfort) precedes jaundice; most cases self-limited.
Major Causes
- Viral β Hep A, B, C, D, E (covered in detail in LO tab 4).
- Drug-induced (DILI) β acetaminophen (most common cause of ALF in the US), INH, amiodarone, halothane, mushrooms (Amanita phalloides).
- Ischemic β shock liver; AST & ALT in thousands, rapid fall.
- Autoimmune hepatitis β covered in LO tab 4.
π¬ Histology
Lobular disarray with apoptotic hepatocytes (Councilman bodies), ballooning degeneration, focal spotty necrosis, and lymphocytic portal & lobular inflammation. Most lobular inflammation concentrates around the central vein (zone 3).
π§ͺ Labs & Clinical
- ALT/AST elevated into hundreds to thousands; ALT usually > AST (except alcohol).
- Bilirubin rises late (mixed pattern).
- PT/INR normal unless progressing toward acute liver failure.
Acetaminophen produces centrilobular (zone 3) necrosis because zone 3 hepatocytes have the highest CYP2E1 activity β most NAPQI produced there. Antidote: N-acetylcysteine (replenishes glutathione). Ischemic injury also hits zone 3 (furthest from arterial supply).
▼Acute & Chronic Liver Failure
β Liver failure = loss of synthetic function (jaundice + coagulopathy + encephalopathy). Acute = < 26 weeks in previously normal liver; chronic = cirrhosis-based (covered in Cirrhosis tab).
β‘ Acute Liver Failure (ALF) β Definition
Triad:
- Coagulopathy β INR > 1.5
- Hepatic encephalopathy β any grade
- No prior liver disease, illness < 26 weeks
Sub-classified as hyperacute (< 7 d β best prognosis, e.g., acetaminophen), acute (1β4 wk), or subacute (4β26 wk β worst prognosis).
Major Causes (know the top 3)
- Acetaminophen (~ 46% of US cases)
- Idiosyncratic DILI
- Viral hepatitis (HAV, HBV; HEV in pregnancy)
Others: autoimmune, Wilson disease (acute presentation), Budd-Chiari, ischemic hepatitis, Amanita mushroom.
π₯ Complications of ALF
- Hepatic encephalopathy & cerebral edema β ammonia-driven; leading cause of death. Treat with lactulose, rifaximin, head elevation, hypertonic saline for ICP.
- Coagulopathy & bleeding β reduced clotting factors.
- Hypoglycemia β failed gluconeogenesis/glycogenolysis.
- Lactic acidosis β impaired lactate clearance.
- Renal failure (hepatorenal syndrome), infection (SBP), multi-organ failure.
π§ Hepatic Encephalopathy β Mechanism
Gut-derived ammonia normally converted to urea by the liver. When the liver fails (or blood is shunted past it via portal-systemic collaterals), ammonia crosses the blood-brain barrier, is taken up by astrocytes, combines with glutamate to form glutamine β osmotic swelling β cerebral edema and altered mentation.
Precipitants (memorize): GI bleed, infection (SBP!), constipation, hypokalemia/alkalosis, dehydration, TIPS, sedatives, high-protein meal.
Signs: asterixis ("liver flap"), day/night reversal, confusion, coma. Stage IβIV.
Treatment: lactulose (traps NHβ as NHββΊ in the colon and purges it) + rifaximin (reduces urease-producing gut bacteria).
- Arterial pH < 7.3, OR
- INR > 6.5 + creatinine > 3.4 mg/dL + grade III/IV encephalopathy
- β meets criteria for emergency liver transplant.
- H β Hypoglycemia
- E β Encephalopathy / cerebral Edema
- P β Platelet + clotting dysfunction (coagulopathy)
- A β Acidosis (lactic)
- T β Toxins build up (ammonia)
- I β Infection (spontaneous bacterial peritonitis)
- C β Cardiorenal failure (hepatorenal syndrome)
Students say"lactulose is a laxative." Not the point. Lactulose is metabolized by colonic bacteria to lactic acid β acidifies colon lumen β NHβ + HβΊ β NHββΊ (ionized, nonabsorbable) β trapped and excreted. The laxative effect is a bonus, not the mechanism.
▼Portal Hypertension
β Portal HTN = sustained elevation of portal venous pressure (HVPG > 5 mmHg; clinically significant > 10 mmHg). Its complications β varices, ascites, splenomegaly, encephalopathy β cause most cirrhosis deaths.
πΊοΈ Causes by Location
| Site | Examples |
|---|---|
| Pre-hepatic | Portal vein thrombosis (hypercoagulable states, pancreatitis, cirrhosis itself), splenic vein thrombosis |
| Intrahepatic β presinusoidal | Schistosomiasis (#1 worldwide), early PBC, sarcoidosis |
| Intrahepatic β sinusoidal | Cirrhosis (most common in US), SOS/VOD |
| Intrahepatic β postsinusoidal | Veno-occlusive disease |
| Post-hepatic | Budd-Chiari (hepatic vein thrombosis), right heart failure, constrictive pericarditis |
π₯ Six Consequences β Memorize
- Varices β porto-systemic collaterals: esophageal (L gastric β azygos), umbilical/caput medusae (paraumbilical veins), anorectal (superior rectal β inferior rectal; not the same as hemorrhoids!), retroperitoneal (rare). Variceal hemorrhage = leading cause of death in portal HTN.
- Ascites β hydrostatic pressure + hypoalbuminemia + nitric-oxideβdriven splanchnic vasodilation β renal NaβΊ/water retention. SAAG β₯ 1.1 g/dL.
- Congestive splenomegaly β thrombocytopenia (hypersplenism).
- Hepatic encephalopathy β systemic shunting of NHβ-rich portal blood past the liver.
- Hepatopulmonary syndrome β intrapulmonary vascular dilations β platypnea, orthodeoxia.
- Hepatorenal syndrome β splanchnic vasodilation β effective arterial underfilling β renal vasoconstriction β AKI.
π©Έ Variceal Bleeding β Management
- Primary prevention: nonselective Ξ²-blockers (propranolol, nadolol) β Ξ²β blockade causes splanchnic vasoconstriction β β portal flow.
- Active bleed: IV octreotide (somatostatin analog β splanchnic vasoconstriction) + endoscopic band ligation + ceftriaxone prophylaxis.
- Refractory: TIPS (transjugular intrahepatic portosystemic shunt) β decompresses but precipitates encephalopathy.
- SAAG = serum albumin β ascitic albumin.
- β₯ 1.1 g/dL: portal HTN (cirrhosis, CHF, Budd-Chiari).
- < 1.1 g/dL: NOT portal HTN β peritoneal carcinomatosis, TB peritonitis, nephrotic, pancreatitis.
Students assume hemorrhoids = portal HTN. Wrong. Hemorrhoids are dilated internal pudendal vein tributaries and occur in people with normal portal pressure. Anorectal varices (true porto-systemic collaterals) form between the superior rectal vein (portal system) and the middle/inferior rectal veins (systemic) β these indicate portal HTN.
π§ Testing Your Understanding!
Testing Your Understanding β LO 1, Question 1
A third-year medical student reviews a liver biopsy from a 16-year-old with a recent viral illness who was given aspirin for fever. The pathologist notes numerous hepatocytes containing many tiny lipid droplets with a centrally-placed nucleus. Name the injury pattern, the specific diagnosis you suspect, and the molecular mechanism.
Consider: micro- vs. macrovesicular steatosis, aspirin & mitochondria, Reye syndrome
Aspirin metabolites (salicylate) inhibit mitochondrial Ξ²-oxidation enzymes, preventing hepatocytes from oxidizing fatty acids. Fatty acids accumulate as many small cytoplasmic droplets around an intact central nucleus = microvesicular steatosis. Clinically: vomiting, hepatomegaly, hypoglycemia, elevated ammonia, and rapidly progressive encephalopathy in a child recovering from a viral illness. Never give aspirin to children with viral illness.
Testing Your Understanding β LO 2, Question 2
A 62-year-old man with a 30-year history of heavy alcohol use has AST 180, ALT 70, bilirubin 2.5, albumin 2.8, INR 1.6. Which labs reflect injury, which reflect function, and which finding specifically suggests alcohol as the driver?
Consider: AST/ALT ratio, synthetic markers, half-life of factor VII
AST and ALT are injury markers (hepatocyte leak). The AST:ALT ratio of 2.6 is classic for alcoholic liver disease β alcohol depletes B6, which ALT requires more than AST; mitochondrial AST is also released. True function is reflected by albumin (2.8 β chronically low) and INR (1.6 β both acute & chronic coagulopathy). Elevated direct bilirubin reflects excretion failure. Albumin's long half-life (~20 d) shows this is chronic, while INR can rise quickly because factor VII has a 6-hour half-life.
Testing Your Understanding β LO 3, Question 3
A 55-year-old with alcoholic cirrhosis develops hematemesis. Endoscopy shows bleeding esophageal varices. Explain the vascular anatomy that creates these varices, why the patient also has splenomegaly and thrombocytopenia, and why propranolol (not metoprolol) is used for prevention.
Consider: porto-systemic collaterals, splanchnic Ξ²β receptors, hypersplenism
Cirrhosis raises portal pressure β blood seeks alternative routes to the systemic circulation. At the gastroesophageal junction, the left gastric (coronary) vein (portal) anastomoses with esophageal branches of the azygos (systemic) β these submucosal collaterals enlarge into varices and rupture. Splenomegaly reflects congestion of the splenic vein (portal tributary) β hypersplenism β sequestration of platelets β thrombocytopenia. Nonselective Ξ²-blockers like propranolol block Ξ²β receptors in splanchnic arterioles β unopposed Ξ±-mediated splanchnic vasoconstriction β β portal inflow β β portal pressure. Selective Ξ²β blockers (metoprolol) lack this splanchnic effect and won't work.
LO 4 β Cirrhosis: End-Stage Chronic Liver Disease
Definition, pathogenesis, causes, histology, and the compensated β decompensated clinical continuum.
- LO 4: Describe the definition, pathogenesis, common causes, histologic features, and clinical consequences of cirrhosis (compensated vs decompensated).
▼Definition & Pathogenesis of Cirrhosis
β Cirrhosis is the end-stage histologic pattern shared by nearly every chronic liver disease. It is defined by diffuse bridging fibrosis + regenerative nodule formation that destroys normal lobular architecture. Once established, it is the substrate for portal hypertension, hepatocellular dysfunction, and hepatocellular carcinoma.
The Core Sequence
Chronic injury β persistent inflammation β hepatic stellate cell (Ito cell) activation β transformation into myofibroblasts β deposition of type I and III collagen in the space of Disse β capillarization of sinusoids (loss of fenestrae) β impaired hepatocyteβsinusoid exchange and increased intrahepatic resistance.
Reversibility
Early fibrosis is reversible if the inciting injury is removed (e.g., sustained virologic response to HCV, alcohol cessation, weight loss in MASLD). Once crosslinked collagen and regenerative nodules are established, reversal is limited β cirrhosis is generally considered irreversible in routine clinical practice.
The"most common preventable cause of hepatic fibrosis" answer depends on population: globally = chronic viral hepatitis; US/Europe = MASLD/alcohol.
▼Major Causes of Cirrhosis
β Any chronic liver insult β metabolic, toxic, viral, autoimmune, biliary, vascular, or genetic β can end in cirrhosis. High-yield causes for USMLE Step 1:
| Category | Disease | Classic Step 1 Clue |
|---|---|---|
| Metabolic | MASLD / MASH | Obesity, T2DM, dyslipidemia; now most common cause in the US |
| Toxic | Alcohol-related liver disease | Mallory-Denk bodies, AST:ALT > 2 |
| Viral | Chronic HBV, HCV | HBsAg + >6mo; anti-HCV + HCV RNA |
| Autoimmune | AIH, PBC, PSC | ANA/ASMA; AMA; p-ANCA + IBD |
| Genetic β iron | Hereditary hemochromatosis | HFE C282Y, βferritin, βtransferrin sat,"bronze diabetes" |
| Genetic β copper | Wilson disease | βceruloplasmin, Kayser-Fleischer rings, young pt with neuropsych sx |
| Genetic β protein | Ξ±1-antitrypsin deficiency | PAS(+) diastase-resistant globules; young nonsmoker w/ emphysema |
| Vascular | Budd-Chiari, cardiac cirrhosis | Nutmeg liver, RHF, myeloproliferative neoplasm |
| Cholestatic | PBC, PSC, biliary atresia | AMA /"beads on a string" / neonate w/ direct hyperbili |
▼Histologic Features
β Three histologic hallmarks define cirrhosis on biopsy: bridging fibrosis, regenerative nodules, and disrupted architecture.
Micronodular vs Macronodular
| Pattern | Nodule Size | Classic Causes |
|---|---|---|
| Micronodular | < 3 mm, uniform | Alcohol, biliary obstruction, hemochromatosis, hepatic venous outflow obstruction |
| Macronodular | > 3 mm, variable | Chronic viral hepatitis, Wilson, Ξ±1-AT, late alcoholic |
| Mixed | Both | Late-stage any cause |
Stains
Trichrome stains collagen blue and highlights bridging fibrosis. Reticulin stain collapses in areas of regeneration and is used to distinguish regenerative nodules from HCC.
▼Compensated vs Decompensated Cirrhosis
β Cirrhosis is a two-phase clinical disease. Compensated patients may be asymptomatic for years; decompensation marks a dramatic drop in survival.
| Feature | Compensated | Decompensated |
|---|---|---|
| Symptoms | Often none; fatigue | Ascites, variceal bleed, encephalopathy, jaundice |
| Synthetic function | Preserved (normal albumin, INR) | β albumin, β INR, β bilirubin |
| Portal HTN signs | Subclinical | Overt β varices, ascites, splenomegaly |
| Median survival | > 12 years | ~2 years (untreated) |
Physical Exam β Stigmata of Chronic Liver Disease
Spider angiomata, palmar erythema, gynecomastia, testicular atrophy, Dupuytren contracture, caput medusae, asterixis, fetor hepaticus, parotid enlargement, jaundice, scleral icterus, terry nails. Hyperestrogenism (from impaired hepatic clearance) drives the angiomata/palmar erythema/gynecomastia triad.
Severity Scores
| Score | Components | Used For |
|---|---|---|
| Child-Pugh | Bilirubin, Albumin, INR, Ascites, Encephalopathy ("ABCDE") | Class A/B/C β general prognosis |
| MELD | Bilirubin, Creatinine, INR, Na | Transplant allocation |
▼Complications of Decompensation
β These six complications define decompensated cirrhosis on Step 1:
1. Ascites & Spontaneous Bacterial Peritonitis (SBP)
Ascites is the most common first sign of decompensation. Driven by portal HTN + splanchnic vasodilation + hypoalbuminemia. SAAG β₯ 1.1 g/dL.
SBP dx: Ascites PMN > 250/mmΒ³. Most common organism: E. coli. Treatment: IV cefotaxime.
Cirrhotic presenting with new confusion, fever, or abdominal pain β paracentesis before antibiotics. A PMN > 250 confirms SBP even if culture negative.
2. Esophageal Varices
Dilated submucosal veins of the distal esophagus from portal β azygos collateral flow. Screen all new cirrhotics by EGD. Primary prophylaxis: nonselective Ξ²-blocker (propranolol, nadolol) or endoscopic variceal ligation. Acute bleed: octreotide + banding + ceftriaxone prophylaxis for SBP.
3. Hepatic Encephalopathy (HE)
Neuropsychiatric syndrome driven by accumulation of ammonia (and other neurotoxins) that bypass the cirrhotic liver via portosystemic shunts. Asterixis is the classic finding. Precipitants ="HEPATIC" (GI bleed, infection, electrolytes, constipation, dehydration, drugs, dietary protein load).
Treatment: Lactulose (traps NH4+ in gut lumen) Β± rifaximin (decreases urease-producing gut flora).
4. Hepatorenal Syndrome (HRS)
Functional renal failure in advanced cirrhosis driven by splanchnic vasodilation β intense renal vasoconstriction. Bland urine, FeNa < 1%, no improvement with volume. Type 1 = rapid (weeks); Type 2 = gradual. Definitive therapy = liver transplant.
5. Hepatopulmonary Syndrome
Triad: liver disease + hypoxemia + intrapulmonary vascular dilatation. Classic finding: platypnea-orthodeoxia (dyspnea/hypoxia worse sitting up).
6. Hepatocellular Carcinoma (HCC)
Cirrhosis of ANY cause is the dominant risk factor for HCC. Highest risk: HBV (even without cirrhosis), HCV, hemochromatosis, aflatoxin-B1 exposure (p53 mutation). Screening: q6mo U/S Β± AFP in all cirrhotics.
π§ Testing Your Understanding!
Testing Your Understanding β LO 4, Question 1
A 54-year-old man with a 30-year history of heavy alcohol use presents with increasing abdominal girth and mild confusion. Exam shows palmar erythema, spider angiomata, and a fluid wave. Labs: albumin 2.6, INR 1.8, total bilirubin 3.4. Diagnostic paracentesis shows SAAG 1.4 and PMN 90. Explain the single mechanism that most directly drives ascites formation in this patient.
Consider: sinusoidal vs pre-sinusoidal portal HTN, SAAG interpretation, RAAS activation from splanchnic vasodilation
Sinusoidal portal hypertension (post-sinusoidal in cirrhosis) drives weeping of hepatic lymph into the peritoneum β this is the primary event. Splanchnic vasodilation (NOT vasoconstriction) is secondary and activates RAAS, producing the NaβΊ and water retention that perpetuates ascites. SAAG β₯ 1.1 confirms portal HTN as the driver; PMN < 250 excludes SBP (though his confusion and low-grade renal changes still warrant vigilance for it).
Testing Your Understanding β LO 4, Question 2
Liver biopsy of a 45-year-old woman with chronic HCV shows nodules 5β10 mm in diameter separated by broad bands of collagen that on trichrome stain bridge portal tracts to central veins. Name the histologic pattern and the typical etiologies it suggests.
Consider: 3 mm nodule cutoff, HCV/HBV/Wilson/Ξ±1-AT associations, bridging fibrosis on trichrome
Nodules > 3 mm define macronodular cirrhosis, classically seen in chronic viral hepatitis (HBV, HCV), Wilson disease, and Ξ±1-antitrypsin deficiency. Micronodular (< 3 mm) cirrhosis suggests alcohol, hemochromatosis, or biliary causes. Trichrome-stained bridging fibrosis with architectural distortion confirms cirrhosis β not simply bridging necrosis.
Testing Your Understanding β LO 4, Question 3
A 60-year-old cirrhotic man is admitted with worsening confusion. Creatinine has risen from 1.0 to 2.8 over 10 days despite volume expansion with albumin. Urine sediment is bland, FeNa is 0.3%. Name the syndrome and the pathophysiologic mechanism.
Consider: bland urine + FeNa < 1%, non-response to albumin volume, splanchnic vasodilation β renal vasoconstriction
Classic Type 1 hepatorenal syndrome (HRS): bland urine, FeNa < 1%, and failure to respond to volume in a cirrhotic differentiate HRS from ATN (muddy-brown casts, FeNa > 2%) and prerenal azotemia (improves with fluids). Mechanism: advanced splanchnic vasodilation β β effective arterial volume β intense renal arteriolar vasoconstriction via RAAS, sympathetic activation, and ADH. Treatment is albumin + splanchnic vasoconstrictors (midodrine/octreotide or terlipressin); definitive management is liver transplant.
LO 5 β Alcohol-Related Liver Disease
Ethanol metabolism, acetaldehyde injury, the steatosis β hepatitis β cirrhosis spectrum, and characteristic histology.
- LO 5: Describe alcohol use guidelines, ethanol metabolism, the role of acetaldehyde in malignancy and tissue injury, and the clinical and histologic spectrum of alcohol-related liver disease (ALD).
▼Alcohol Use Thresholds
β One US standard drink = 14 g of pure ethanol (12 oz beer β 5% ABV, 5 oz wine β 12%, 1.5 oz spirits β 40%).
| Category | Women | Men |
|---|---|---|
| Low-risk limit (US dietary guidelines) | β€ 1 drink/day | β€ 2 drinks/day |
| Heavy use (NIAAA) | > 3/day or > 7/week | > 4/day or > 14/week |
| Binge drinking | β₯ 4 drinks in 2 h | β₯ 5 drinks in 2 h |
▼Ethanol Metabolism
β Three enzyme systems convert ethanol β acetaldehyde, which is then detoxified to acetate.
The Three Pathways
| Pathway | Enzyme | Location | Role |
|---|---|---|---|
| Primary | Alcohol dehydrogenase (ADH) | Hepatocyte cytosol | Ethanol β acetaldehyde; generates NADH |
| Second step | Aldehyde dehydrogenase (ALDH2) | Mitochondria | Acetaldehyde β acetate; generates NADH |
| Inducible | CYP2E1 / MEOS | Smooth ER | Induced by chronic use β tolerance + ROS |
| Minor | Catalase | Peroxisomes | < 5% of total |
- Pyruvate β lactate β lactic acidosis
- OAA β malate β fasting hypoglycemia (gluconeogenesis blocked)
- DHAP β glycerol-3-P β hepatic steatosis (β TG synthesis)
- β ketone production β alcoholic ketoacidosis
ALDH2 Polymorphism β"Asian Flushing"
A common ALDH2*2 variant (prevalent in East Asian populations) produces inactive ALDH2. Acetaldehyde accumulates after drinking β flushing, tachycardia, nausea (similar to disulfiram reaction).
Disulfiram irreversibly inhibits ALDH (not ADH). Fomepizole inhibits ADH and is used for methanol / ethylene glycol poisoning.
▼Acetaldehyde, ROS, & Malignancy
β Acetaldehyde is a Group 1 carcinogen (IARC). It forms DNA adducts and interferes with DNA repair.
Mechanisms of Tissue Injury
- Acetaldehyde-protein adducts: trigger innate immunity + autoantibodies β hepatic inflammation.
- CYP2E1 induction: generates reactive oxygen species β lipid peroxidation, mitochondrial damage.
- Gut permeability: ethanol loosens tight junctions β portal LPS β Kupffer cell TLR4 activation β TNFΞ±.
- Nutritional deficits: thiamine (WernickeβKorsakoff), folate, B6, zinc.
Alcohol-Associated Cancers
Ethanol (via acetaldehyde) increases risk for cancers of the oropharynx, larynx, esophagus (squamous cell), liver (HCC), breast, and colon. Risk is synergistic with tobacco for upper aerodigestive cancers.
▼Clinical Spectrum of Alcohol-Related Liver Disease
β ALD progresses along a three-stage continuum. Early stages are reversible with abstinence.
| Stage | Reversibility | Key Features | Classic Labs / Imaging |
|---|---|---|---|
| Steatosis (fatty liver) | Fully reversible | Asymptomatic; hepatomegaly; seen in > 90% of heavy drinkers | Hyperechoic liver on U/S; Β± mild β LFTs |
| Alcoholic hepatitis | Partially reversible | Fever, jaundice, RUQ pain, leukocytosis, tender hepatomegaly | AST > ALT (2:1); AST rarely > 500; β GGT; β bilirubin/INR |
| Alcoholic cirrhosis | Irreversible | Stigmata of CLD, portal HTN, decompensation | Nodular liver, β MELD; complications as in LO4 |
AST:ALT Ratio
AST > ALT with a ratio > 2 is highly suggestive of alcoholic injury. Two reasons:
- Alcohol depletes pyridoxal-5-phosphate (B6), a cofactor more important for ALT than AST.
- Alcohol causes mitochondrial injury, and AST is released from both cytosol and mitochondria.
Severity & Treatment
Maddrey discriminant function (DF β₯ 32) or MELD β₯ 20 identifies severe alcoholic hepatitis. Treatment: cessation, nutrition (thiamine, folate), and selective use of prednisolone in severe disease without active infection.
▼Histologic Hallmarks
β On biopsy, alcoholic hepatitis has a characteristic triad: Mallory-Denk bodies, neutrophilic inflammation, and perivenular fibrosis.
| Finding | Description | Significance |
|---|---|---|
| Macrovesicular steatosis | Large single fat vacuole displacing nucleus | Earliest and most universal finding |
| Hepatocyte ballooning | Swollen, rarefied cytoplasm | Marker of active injury |
| Mallory-Denk bodies | Eosinophilic intracytoplasmic inclusions of damaged intermediate filaments (cytokeratin 8/18) | Classic but not pathognomonic β also seen in MASH, Wilson, PBC |
| Neutrophilic satellitosis | PMNs clustering around ballooned hepatocytes with Mallory bodies | Highly suggestive of alcoholic hepatitis |
| Perivenular (zone 3) fibrosis | "Chicken-wire" pericellular/perisinusoidal fibrosis radiating from central vein | Earliest fibrosis pattern of ALD |
π§ Testing Your Understanding!
Testing Your Understanding β LO 5, Question 1
A 48-year-old man is admitted after three days of jaundice, fever, and RUQ pain. He reports drinking a fifth of whiskey daily for the past 15 years. AST 320, ALT 120, GGT 900, total bilirubin 14, INR 1.9. Explain the biochemical mechanism that most directly produces the AST:ALT ratio seen here.
Consider: B6 (pyridoxal-5-phosphate) as ALT cofactor, mitochondrial isoform of AST, the 2:1 ratio rule
Chronic ethanol use depletes pyridoxal-5-phosphate (B6), which is a more critical cofactor for ALT than for AST; as a result, ALT activity falls disproportionately in alcoholics. A second contributor is that alcohol injures mitochondria, and mitochondrial AST (the M-isoform) leaks into the serum β further elevating AST. Net result: the pathognomonic AST:ALT > 2:1 seen in alcoholic liver disease. Note: most other hepatocellular injuries show ALT > AST.
Testing Your Understanding β LO 5, Question 2
A liver biopsy from a heavy drinker shows ballooned hepatocytes with pink intracytoplasmic inclusions surrounded by neutrophils, together with perivenular "chicken-wire" fibrosis radiating from central veins. Identify the inclusion, its protein composition, and other conditions that show it.
Consider: eosinophilic intracytoplasmic inclusions, intermediate filament proteins, zone-3 "chicken-wire" fibrosis
Mallory-Denk bodies are aggregates of misfolded keratin 8/18 intermediate filaments β ropey, eosinophilic, and immediately adjacent to the nucleus. They are classic for alcoholic hepatitis but are not specific: MASH, Wilson disease, primary biliary cholangitis, and chronic cholestasis can all show them. The perivenular "chicken-wire" fibrosis around central veins is the other ALD histologic signature (zone-3 injury).
Testing Your Understanding β LO 5, Question 3
A 26-year-old woman of East Asian descent develops severe facial flushing, palpitations, and nausea minutes after a single glass of wine. Name the enzyme deficiency, the toxic intermediate that accumulates, and the pharmacologic analogy.
Consider: East Asian population genetics, acetaldehyde accumulation, disulfiram-like reaction
The ALDH2*2 variant (prevalent in East Asian populations) produces an inactive aldehyde dehydrogenase. After ADH converts ethanol to acetaldehyde, ALDH2 cannot detoxify it to acetate β so acetaldehyde accumulates, producing flushing, tachycardia, nausea, and headache. Pharmacologic parallel: disulfiram irreversibly inhibits ALDH and is used to create aversion. Fomepizole (for methanol/ethylene glycol) blocks ADH instead, which works farther upstream.
LOs 6β8 β Viral & Autoimmune Hepatitis
Hepatotropic viruses AβE, HBV serology, acute vs chronic infection, extrahepatic sequelae, and autoimmune hepatitis.
- LO 6: Distinguish the hepatotropic viruses (HAVβHEV) by route, course, serology, and complications.
- LO 7: Differentiate acute from chronic viral hepatitis clinically and histologically, and describe extrahepatic manifestations.
- LO 8: Recognize the types, serologies, and histologic features of autoimmune hepatitis (AIH).
▼Hepatotropic Viruses AβE
β Five viruses specifically target hepatocytes. The exam loves route, chronicity, and pregnancy risk.
| Virus | Family / Genome | Transmission | Chronicity | Key Clue |
|---|---|---|---|---|
| HAV | Picornavirus (ssRNA+) | Fecal-oral (shellfish, travel) | Never | Self-limited, pediatric, IgM anti-HAV |
| HBV | Hepadnavirus (partially dsDNA) | Blood, sex, perinatal | ~5% adults, >90% neonates | Only DNA; HCC even without cirrhosis |
| HCV | Flavivirus (ssRNA+) | Blood (IVDU, transfusion pre-1992) | ~75β85% | "Silent" chronic β cirrhosis/HCC |
| HDV | Deltavirus (ssRNA-) β defective | Blood/sex; needs HBsAg | Coinfection β HBV; superinfection = severe | Only replicates with HBV |
| HEV | Hepevirus (ssRNA+) | Fecal-oral (contaminated water) | Usually none | High mortality (~20%) in pregnancy |
Risk of chronic HBV is inverse to age at infection: > 90% of perinatally infected neonates become chronic; only ~5% of infected adults.
▼HBV Serology β The Step 1 Classic
β Know the five HBV markers cold and be able to stage any patient.
| Marker | Meaning |
|---|---|
| HBsAg | Active infection (acute or chronic). First to appear. |
| anti-HBs | Immunity (from infection or vaccination). |
| HBeAg | High infectivity, active replication. |
| anti-HBe | Low infectivity, resolving or inactive. |
| anti-HBc IgM | Acute infection OR window period (only positive test). |
| anti-HBc IgG | Past or chronic infection. Not made by vaccination. |
Stage Patterns
| Stage | HBsAg | anti-HBs | anti-HBc IgM | anti-HBc IgG | HBeAg |
|---|---|---|---|---|---|
| Acute | + | β | + | β | + |
| Window | β | β | + | β | β |
| Resolved infection | β | + | β | + | β |
| Chronic (active) | + | β | β | + | + |
| Chronic (inactive) | + | β | β | + | β |
| Vaccinated | β | + | β | β | β |
Eosinophilic"ground-glass" cytoplasm on H&E = accumulated HBsAg in the ER. Pathognomonic for chronic HBV.
▼Acute Viral Hepatitis
β Acute viral hepatitis = hepatocyte injury with ALT > AST (except ALD/ischemia) + viral serologies.
Clinical Phases
- Prodrome: malaise, anorexia, nausea,"flu-like" symptoms, distaste for cigarettes.
- Icteric phase: jaundice, RUQ pain, tender hepatomegaly, Β± dark urine (bilirubinuria), pale stools.
- Convalescence: LFTs normalize over weeks.
Histology of Acute Viral Hepatitis
- Panlobular lymphocytic infiltrate.
- Councilman bodies β eosinophilic apoptotic hepatocytes (also in yellow fever).
- Ballooning degeneration.
- Lobular disarray.
- Severe cases: bridging or submassive necrosis.
▼Chronic Viral Hepatitis & Extrahepatic Disease
β Chronic hepatitis = biochemical OR virologic inflammation > 6 months. Only HBV, HCV, and HDV chronic.
Histology
- Portal/periportal lymphocytic infiltrate.
- Interface hepatitis ("piecemeal necrosis") β lymphocytes spill into the lobule across the limiting plate.
- Progressive portal-portal / portal-central bridging fibrosis β cirrhosis.
- Ground-glass cytoplasm (HBV); lymphoid aggregates + steatosis (HCV).
Extrahepatic Manifestations
| Virus | Extrahepatic Condition |
|---|---|
| HBV | Polyarteritis nodosa (PAN), membranous nephropathy, serum sicknessβlike syndrome |
| HCV | Mixed essential cryoglobulinemia (type II), membranoproliferative glomerulonephritis, porphyria cutanea tarda, lichen planus, non-Hodgkin lymphoma |
| HBV/HCV | Aplastic anemia, cirrhosis, HCC |
▼Autoimmune Hepatitis (AIH)
β AIH is a chronic immune-mediated hepatitis, classically in young to middle-aged women with other autoimmune disease.
Two Types
| Feature | Type 1 | Type 2 |
|---|---|---|
| Demographic | Adults (>90% of cases); F:M 4:1 | Children / adolescents; predominantly girls |
| Autoantibodies | ANA, ASMA (anti-smooth muscle), anti-actin, anti-SLA | Anti-LKM1, anti-LC1 |
| Severity | Variable; responds to steroids | Often more severe; more relapses |
Histology
- Interface hepatitis with a plasma-cell rich infiltrate (rosettes of hepatocytes).
- Bridging fibrosis with progression to cirrhosis.
Treatment
Prednisone Β± azathioprine. 80β90% achieve remission; relapse is common after taper. Liver transplant is curative in refractory disease.
AMA (antimitochondrial) β primary biliary cholangitis (PBC), middle-aged women with pruritus.
ASMA/ANA β autoimmune hepatitis (AIH).
p-ANCA + IBD β primary sclerosing cholangitis (PSC).
π§ Testing Your Understanding!
Testing Your Understanding β LOs 6β8, Question 1
A 28-year-old man presents with jaundice, RUQ pain, and malaise 6 weeks after a needlestick exposure. Labs: HBsAg negative, anti-HBs negative, anti-HBc IgM positive. Name the stage of HBV infection and explain the serologic significance.
Consider: timing between HBsAg clearance and anti-HBs appearance, isolated anti-HBc IgM, how vaccination differs from natural infection
HBV window period: HBsAg has cleared but anti-HBs has not yet risen to detectable levels. The only marker of recent infection during this window is anti-HBc IgM β this is the one clinical scenario in which IgM anti-HBc is the sole positive test. Contrast: resolved infection shows +anti-HBs / +anti-HBc IgG; vaccination shows +anti-HBs only (no anti-HBc).
Testing Your Understanding β LOs 6β8, Question 2
A 55-year-old woman with chronic HCV develops palpable purpura on the legs, arthralgias, peripheral neuropathy, and hematuria with RBC casts. Renal biopsy shows membranoproliferative glomerulonephritis with "tram-track" appearance. Identify the extrahepatic syndrome and the key serum finding.
Consider: palpable purpura + MPGN + neuropathy triad, cold-precipitating immune complexes, HCV extrahepatic manifestations
Classic HCV-associated mixed essential cryoglobulinemia. Type II cryoglobulins (monoclonal IgM-ΞΊ rheumatoid factor + polyclonal IgG) precipitate in cool extremities β immune-complex small-vessel vasculitis: palpable purpura, arthralgias, neuropathy, and MPGN with low C4. Rheumatoid factor is typically positive. HCV is the strongest association; treat the underlying HCV.
Testing Your Understanding β LOs 6β8, Question 3
A 24-year-old woman presents with fatigue, jaundice, and arthralgias. AST 650, ALT 800, total bilirubin 7.2, Ξ³-globulin markedly elevated. ANA 1:640, ASMA positive, AMA negative. Liver biopsy shows interface hepatitis with a plasma-cell rich portal infiltrate. Name the diagnosis, subtype, and best initial therapy.
Consider: young woman + plasma-cell interface hepatitis, ASMA/ANA positivity, first-line immunosuppression with steroid-sparing agent
Type 1 Autoimmune Hepatitis (AIH) β the adult presentation with ANA and/or ASMA positivity, elevated IgG/Ξ³-globulin, and characteristic plasma-cellβrich interface hepatitis on biopsy. First-line therapy is prednisone (or prednisone + azathioprine); azathioprine is added as a steroid-sparing agent for long-term maintenance. Ursodeoxycholic acid is for PBC (AMA-positive); tenofovir is for HBV.
LOs 9β10 β Vascular Disease of the Liver
Chronic passive congestion, Budd-Chiari syndrome, sinusoidal obstruction syndrome, and cardiac cirrhosis.
- LO 9: Describe chronic passive congestion of the liver and its gross/histologic"nutmeg" appearance.
- LO 10: Identify causes, clinical features, and complications of hepatic venous outflow obstruction (Budd-Chiari, SOS/VOD, cardiac cirrhosis).
▼Chronic Passive Congestion β"Nutmeg Liver"
β Elevated central venous pressure (any cause of right-sided heart failure) is transmitted back through the IVC and hepatic veins β stagnant blood in the central vein and zone 3 sinusoids.
Gross Appearance
On cut section: dark red centrilobular congestion surrounded by pale periportal (zone 1) hepatocytes β the mottled red-and-tan pattern of a cut nutmeg seed.
Histology
- Centrilobular (zone 3) congestion of sinusoids.
- Centrilobular hepatocyte atrophy / necrosis β zone 3 is furthest from oxygenated portal blood.
- With prolonged congestion: centrilobular (zone 3) fibrosis β ultimately cardiac cirrhosis.
▼Causes of Hepatic Venous Outflow Obstruction
β Obstruction can occur at three anatomic levels. Localization matters because presentation and imaging differ.
| Level of Obstruction | Disease | Classic Causes |
|---|---|---|
| Post-sinusoidal β small central veins | Sinusoidal obstruction syndrome (SOS/VOD) | Stem-cell transplant conditioning, pyrrolizidine alkaloids (bush teas), oxaliplatin |
| Large hepatic veins / IVC | Budd-Chiari syndrome | Polycythemia vera, other MPNs (JAK2), antiphospholipid syndrome, OCPs, pregnancy, HCC invasion |
| Supra-hepatic (right heart) | Cardiac cirrhosis / passive congestion | Right-sided HF, constrictive pericarditis, severe TR |
▼Budd-Chiari Syndrome
β Occlusion of the large hepatic veins and/or hepatic segment of the IVC, most often thrombotic.
Triad
Abdominal pain + hepatomegaly + ascites. Caudate lobe is often spared (it drains directly into the IVC) and becomes hypertrophied on imaging β a classic Step 1 clue.
Risk Factors β"Hypercoagulable Liver"
- Polycythemia vera and other JAK2+ myeloproliferative neoplasms (most common identified cause).
- Antiphospholipid syndrome.
- Paroxysmal nocturnal hemoglobinuria.
- Pregnancy, oral contraceptives.
- Hepatocellular carcinoma invading the hepatic vein.
Diagnosis & Treatment
Doppler U/S is first-line (absent or reversed flow in hepatic veins). Confirm with MR/CT venography. Treat with anticoagulation; TIPS or transplant for fulminant disease.
Think Budd-Chiari, not simple hepatic steatosis or viral hepatitis. Always probe for MPN, APLS, or prothrombotic states.
▼Sinusoidal Obstruction Syndrome (SOS / VOD)
β Non-thrombotic obstruction of small centrilobular venules and sinusoids by sloughed endothelial/sinusoidal debris and subintimal collagen.
Classic Setting
- First 3 weeks after hematopoietic stem-cell transplant conditioning (cyclophosphamide, busulfan).
- Ingestion of pyrrolizidine alkaloids (bush teas containing Senecio, Crotalaria, comfrey).
- Oxaliplatin chemotherapy (for metastatic colorectal cancer).
Presentation
Rapid onset of tender hepatomegaly, weight gain, ascites, and jaundice. Doppler: patent hepatic veins (distinguishes from Budd-Chiari).
▼Cardiac Cirrhosis & Complications
β Decades of chronic passive congestion β centrilobular fibrosis β cardiac cirrhosis.
Clinical Features
- Hepatomegaly with a pulsatile liver (severe TR).
- Hepatojugular reflux.
- Mild transaminase elevation, but LFTs often near-normal despite advanced disease.
- Ascites that is classically high-SAAG, high-protein (> 2.5 g/dL) β distinguishes cardiac ascites from cirrhotic ascites.
Acute"Shock Liver" vs Chronic Congestion
| Feature | Shock / Ischemic Hepatitis | Chronic Congestion |
|---|---|---|
| Onset | Acute (hypotension, sepsis, HF) | Months to years |
| Labs | AST/ALT > 1000, LDH high | Mild AST/ALT β, β ALP |
| Histology | Zone 3 coagulative necrosis | Zone 3 congestion, fibrosis |
π§ Testing Your Understanding!
Testing Your Understanding β LOs 9β10, Question 1
An autopsy of a 76-year-old man with long-standing severe tricuspid regurgitation shows a mottled red-and-tan liver on cut section with congested central veins surrounded by pale periportal hepatocytes. Name the gross appearance, the acinar zone most affected, and why.
Consider: direction of venous drainage, which zone is farthest from oxygenated portal blood, the red-and-tan "nutmeg" gross
The gross is a "nutmeg liver" of chronic passive congestion. Congestion is transmitted back through the central vein into zone 3 sinusoids, producing red, blood-filled zones around central veins (dark stripes) alternating with paler periportal zone 1 (light stripes). Zone 3 is also the most vulnerable to hypoxic injury because it sits farthest from the oxygenated portal blood supply β hence why ischemic and toxic injuries center there.
Testing Your Understanding β LOs 9β10, Question 2
A 32-year-old woman with known polycythemia vera presents with 4 weeks of worsening abdominal pain, massive hepatomegaly, and tense ascites. Doppler ultrasound shows absent flow in the hepatic veins; the caudate lobe is markedly enlarged. Name the syndrome and explain the caudate lobe sign.
Consider: JAK2+ polycythemia vera, caudate lobe drainage directly to IVC, Doppler flow in hepatic veins
Budd-Chiari syndrome β thrombotic occlusion of the hepatic veins. JAK2-positive myeloproliferative neoplasms are a leading predisposing condition. The caudate lobe is characteristically spared and enlarges because it drains directly into the IVC via separate emissary veins rather than through the main hepatic veins. Distinguishes from SOS/VOD (patent hepatic veins on Doppler) and from portal vein thrombosis (patent hepatic veins; presinusoidal picture).
Testing Your Understanding β LOs 9β10, Question 3
A 45-year-old man develops painful hepatomegaly, 6 kg weight gain, and jaundice 10 days after allogeneic HSCT for AML conditioned with busulfan and cyclophosphamide. Doppler U/S shows patent hepatic veins and a patent portal vein with reversed flow. Name the syndrome and the best specific therapy.
Consider: sinusoidal endothelial injury post-HSCT, why hepatic veins remain patent, FDA-approved endothelial-protective therapy
Sinusoidal Obstruction Syndrome (SOS / veno-occlusive disease) β classic presentation 1β3 weeks after myeloablative HSCT. Conditioning chemotherapy damages sinusoidal endothelial cells, causing occlusion at the sinusoidal level (hepatic veins remain patent β this differentiates it from Budd-Chiari). Specific therapy is defibrotide, which has pro-fibrinolytic and endothelial-protective actions and is FDA-approved. Supportive care includes fluid management and avoidance of hepatotoxins.
Practice Questions β USMLE Step 1 Style
25 high-yield vignettes organized by learning objective. Click"Reveal Answer" after committing to your choice.
LO 1 β Liver Injury Patterns (Q1βQ2)
Q1. A 37-year-old man is found unresponsive 6 hours after ingesting an unknown quantity of acetaminophen. Admission labs: AST 7400, ALT 8200, INR 3.1, total bilirubin 5.1. Liver biopsy shows confluent necrosis extending from central veins. Which zone of the hepatic acinus is preferentially injured?
A. Zone 1 (periportal)
B. Zone 2 (midzonal)
C. Zone 3 (centrilobular)
D. Zones 1 and 2 simultaneously
Q2. A 52-year-old woman has been taking isoniazid for latent TB. She presents with jaundice, tender hepatomegaly, and nausea. AST 1100, ALT 1450, total bilirubin 6.2, ALP 140. Her biopsy shows panlobular lymphocytic infiltrate with scattered apoptotic hepatocytes. This histologic pattern is best classified as:
A. Chronic cholestatic hepatitis
B. Steatohepatitis
C. Acute hepatitic injury pattern
D. Granulomatous hepatitis
LO 2 β Liver Function Tests (Q3βQ4)
Q3. A 66-year-old woman with advanced cirrhosis is evaluated for transplant listing. Which combination of labs best reflects synthetic liver function?
A. AST, ALT, GGT
B. Albumin, PT/INR, total bilirubin
C. Alkaline phosphatase and GGT
D. Ammonia and LDH
Q4. A 30-year-old woman has asymptomatic isolated ALP elevation at 340 U/L; GGT is also elevated. All other LFTs are normal. Which single test best confirms that the ALP is of hepatic origin?
A. Serum Ξ³-glutamyl transferase (GGT)
B. Serum calcium
C. Ferritin
D. Uric acid
LO 3 β Jaundice & Cholestasis (Q5βQ8)
Q5. A 19-year-old medical student notices mild scleral icterus after an all-nighter before exams. Total bilirubin 3.1 (indirect 2.8), AST/ALT normal, ALP normal, CBC normal, reticulocyte count normal. Hemolysis labs are negative. Most likely diagnosis?
A. Dubin-Johnson syndrome
B. Rotor syndrome
C. Gilbert syndrome
D. Crigler-Najjar type II
Q6. A 45-year-old woman presents with pruritus and fatigue. Labs: ALP 620, GGT elevated, AST/ALT mildly elevated, total bilirubin 2.0 with direct fraction predominant. AMA is positive at 1:320. Which diagnosis is most likely?
A. Primary sclerosing cholangitis
B. Primary biliary cholangitis
C. Autoimmune hepatitis
D. Acute viral hepatitis
Q7. A 28-year-old man with ulcerative colitis develops cholestatic LFTs. MRCP shows multifocal intra- and extra-hepatic bile duct strictures producing a"beaded" appearance. AMA is negative, p-ANCA is positive. Which complication is he at highest lifetime risk for?
A. Hepatocellular carcinoma
B. Cholangiocarcinoma
C. Pancreatic adenocarcinoma
D. Gastric MALT lymphoma
Q8. A 24-year-old man presents with painless jaundice; labs show total bilirubin 4.5 with elevated direct fraction, normal ALT/AST/ALP. Liver biopsy shows a grossly black liver. Which transporter is defective?
A. UGT1A1
B. MRP2 (ABCC2) canalicular transporter
C. OATP sinusoidal uptake
D. Bile salt export pump (BSEP)
LO 4 β Cirrhosis & Decompensation (Q9βQ11)
Q9. A 58-year-old man with compensated cirrhosis from HCV is admitted with fever 38.6Β°C, diffuse abdominal pain, and confusion. Paracentesis: PMN 520/mmΒ³, SAAG 1.6, total protein 0.8 g/dL. Gram stain negative. Best next step?
A. Repeat paracentesis in 48 hours
B. Start IV cefotaxime now
C. Await culture before antibiotics
D. Start oral norfloxacin only
Q10. A 60-year-old cirrhotic man develops a massive upper GI bleed from esophageal varices. After endoscopic banding and octreotide, which of the following reduces his infectious mortality?
A. Proton pump inhibitor
B. Non-selective Ξ²-blocker
C. Prophylactic ceftriaxone
D. Fresh frozen plasma
Q11. A 55-year-old man with known cirrhosis develops progressive confusion, lethargy, and asterixis over 3 days. He has been constipated. Exam: no fever, no focal findings. Best initial therapy for his encephalopathy?
A. IV thiamine
B. Lactulose
C. Haloperidol
D. High-protein feeding
LO 5 β Alcohol-Related Liver Disease (Q12βQ15)
Q12. A 41-year-old man drinks a pint of vodka daily. Fasting labs show glucose 48 mg/dL, lactate elevated, Ξ²-hydroxybutyrate elevated. Which NADH-driven step best explains his hypoglycemia?
A. Pyruvate β lactate
B. Oxaloacetate β malate
C. Acetyl-CoA β ketones
D. Dihydroxyacetone-P β glycerol-3-P
Q13. A patient with a 20-year drinking history is admitted with fever, jaundice, and tender hepatomegaly. AST 280, ALT 95, GGT 1100, INR 2.0. Biopsy shows ballooned hepatocytes with eosinophilic intracytoplasmic inclusions surrounded by neutrophils and perivenular fibrosis. Which statement about the eosinophilic inclusions is correct?
A. They are pathognomonic for alcoholic hepatitis
B. They are composed of damaged keratin 8/18 intermediate filaments
C. They stain positive for PAS and are diastase-resistant
D. They represent iron deposition
Q14. Chronic ethanol abuse up-regulates CYP2E1 (MEOS). A direct consequence of this induction is:
A. Decreased acetaminophen toxicity
B. Increased conversion of acetaminophen to NAPQI
C. Decreased warfarin clearance
D. Decreased tolerance to alcohol
Q15. A 50-year-old man with alcoholic hepatitis has a Maddrey discriminant function of 38 and no active infection. Which therapy is most likely to reduce short-term mortality?
A. Pentoxifylline alone
B. Oral prednisolone
C. N-acetylcysteine alone
D. Spironolactone
LO 6 β Viral Hepatitis Types (Q16βQ17)
Q16. A 24-year-old woman in her third trimester returns from rural South Asia with fever, jaundice, and malaise. Total bilirubin 9, AST 1200, ALT 1400, INR 2.6. Which virus is most concerning given the clinical context?
A. HAV
B. HBV
C. HCV
D. HEV
Q17. An IV drug user with known chronic HBV develops a sudden, severe deterioration with ALT 3100 and INR 3.0. Which superimposed infection is most likely?
A. Hepatitis A superinfection
B. Hepatitis D superinfection
C. Hepatitis C coinfection
D. Hepatitis E
LO 7 β Acute vs Chronic Viral Hepatitis (Q18βQ19)
Q18. A 45-year-old man with chronic HCV is found to have a serum cryoprecipitate and new membranoproliferative glomerulonephritis on biopsy. The direct mechanism of the renal lesion is:
A. Anti-GBM antibody deposition
B. Immune complexes containing HCV antigens + IgM rheumatoid factor depositing in glomeruli
C. Direct HCV infection of podocytes
D. Complement deficiency
Q19. A liver biopsy from a patient with chronic HBV shows portal-based lymphocytic infiltrates that spill across the limiting plate into the lobule, along with"ground-glass" hepatocytes on H&E. The lymphocytic activity described is termed:
A. Bridging necrosis
B. Interface hepatitis (piecemeal necrosis)
C. Councilman body formation
D. Granulomatous hepatitis
LO 8 β Autoimmune Hepatitis (Q20βQ21)
Q20. A 10-year-old girl is evaluated for fatigue and transaminase elevation. ALT 540, AST 380, Ξ³-globulin elevated. ANA negative, ASMA negative, AMA negative, but anti-LKM1 positive. Which diagnosis fits best?
A. Autoimmune hepatitis type 1
B. Autoimmune hepatitis type 2
C. Primary biliary cholangitis
D. Wilson disease
Q21. Which histologic feature most favors autoimmune hepatitis over chronic viral hepatitis on biopsy?
A. Ground-glass cytoplasm
B. Lymphoid aggregates in portal tracts
C. Plasma-cell rich interface hepatitis with hepatocyte rosettes
D. Steatosis
LO 9 β Chronic Passive Congestion (Q22βQ23)
Q22. A 70-year-old woman with severe tricuspid regurgitation has a cut section of liver at autopsy showing red-purple centrilobular areas surrounded by tan-yellow peripheral hepatocytes. This gross appearance is best described as:
A. Micronodular cirrhosis
B. Nutmeg liver
C. Steatosis
D. Cardiac cirrhosis
Q23. Ascites from chronic right-sided heart failure and cardiac cirrhosis is typically:
A. SAAG < 1.1, high protein
B. SAAG β₯ 1.1, low protein (< 2.5 g/dL)
C. SAAG β₯ 1.1, high protein (β₯ 2.5 g/dL)
D. SAAG < 1.1, low protein
LO 10 β Hepatic Venous Outflow Obstruction (Q24βQ25)
Q24. A 34-year-old woman on OCPs is admitted with 2 weeks of painful hepatomegaly and new ascites. Doppler U/S shows absent flow in all three hepatic veins and marked caudate lobe enlargement. JAK2 V617F is positive. Treatment strategy should include:
A. Observation only
B. Immediate anticoagulation and evaluation for TIPS
C. Defibrotide
D. Ursodeoxycholic acid
Q25. A 48-year-old man develops painful hepatomegaly, 7 kg weight gain, and jaundice 14 days after HSCT conditioning with cyclophosphamide and busulfan. Doppler U/S: hepatic veins patent, no thrombus. Which of the following best differentiates his condition from Budd-Chiari on imaging?
A. Caudate lobe hypertrophy
B. Patent hepatic veins
C. Reversed portal flow
D. Presence of ascites